Ajanta Pharma Ltd

NSE :AJANTPHARM   BSE :532331  Sector : Pharmaceuticals
Buy, Sell or Hold AJANTPHARM? Ask The Analyst

BSE

prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE

prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

15 May
2394.90
(-1.78%)
14 May
2438.25
(2.44%)
13 May
2380.25
(0.12%)
10 May
2377.40
(-1.34%)
09 May
2409.65
(1.77%)
08 May
2367.70
(-1.26%)
07 May
2398.00
(-0.69%)
06 May
2414.55
(1.29%)
03 May
2383.85
(6.71%)
02 May
2234.00
(0.84%)
30 Apr
2215.45
(0.13%)
29 Apr
2212.60
(0.87%)
26 Apr
2193.50
(2.50%)
25 Apr
2139.95
(0.29%)
24 Apr
2133.70
(0.16%)
23 Apr
2130.35
(1.86%)
22 Apr
2091.35
(0.29%)
19 Apr
2085.40
(0.32%)
18 Apr
2078.85
(0.67%)
16 Apr
2064.95
(-2.49%)
15 Apr
2117.75
(0.12%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Bullish
Medium Term Investors

Very Bullish
Long Term Investors

Very Bullish

Moving Averages

5 DMA
Bearish

2400.15

10 DMA
Bullish

2379.15

20 DMA
Bullish

2257.23

50 DMA
Bullish

2189.78

100 DMA
Bullish

2167.38

200 DMA
Bullish

1977.57


Intraday Support and Resistance
(Based on Pivot Points) |

Updated On May 15, 2024 04:00 PM For Next Trading Session

Pivots Classic Fibonacci Camarilla Woodie DM
R3 2502.74 2475.87 2413.42 - -
R2 2475.87 2450.14 2407.25 2472.46 -
R1 2435.39 2434.25 2401.07 2428.57 2455.63
P 2408.52 2408.52 2408.52 2405.11 2418.64
S1 2368.04 2382.79 2388.73 2361.22 2388.28
S2 2341.17 2366.9 2382.55 2337.76 -
S3 2300.69 2341.17 2376.38 - -

Key Metrics

EPS

64.11

P/E

37.35

P/B

8.83

Dividend Yield

2.14%

Market Cap

30,156 Cr.

Face Value

2

Book Value

271.09

ROE

17.68%

EBITDA Growth

312.82 Cr.

Debt/Equity

0.01

Shareholding Pattern

  66.21% Total Promoter Holding
14.76% Mutual Fund Holdings
8.54% FIIs
7.76% Non Institution
2.16% Insurance Companies
0% Custodians
0.57% Other Parties

Shareholding History

Quarterly Result (Figures in Rs. Crores)


Ajanta Pharma Ltd Quaterly Results


Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
INCOME 918.67 1052.79 1049.77 1118.74 1089.58
PROFIT 122.25 208.12 195.3 210.03 202.72
EPS 9.54 16.53 15.51 16.68 16.1

Ajanta Pharma Ltd Quaterly Results


Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
INCOME 885.61 1046.04 997.34 1099.02 959.75
PROFIT 117.21 212.04 212.36 220.15 162.69
EPS 9.15 16.84 16.87 17.48 12.92

Profit & Loss (Figures in Rs. Crores)


Ajanta Pharma Ltd Profit & Loss


Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
INCOME 1216.03 1483.02 1819.79 2017.74 2199.14 2133.06 2696.81 3066.57 3539.84 3815.52
PROFIT 233.88 314.81 416.7 509.77 468.65 387.14 470.53 651.29 713.28 594.01
EPS 17.2 22.94 31.33 38.2 35.32 29.41 35.55 50.13 55.34 46.54

Ajanta Pharma Ltd Profit & Loss


Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
INCOME 1120.5 1380.68 1701.48 1863.99 1947.51 1942.15 2371.6 2896.76 3336.97 3566.01
PROFIT 220.38 310.37 423.05 502.84 427.53 391.94 444.02 672.73 720.48 545.85
EPS 16.21 22.67 31.8 37.67 32.22 29.78 33.53 51.8 55.9 44.22

Balance Sheet (Figures in Rs. Crores)

Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
SOURCES OF FUNDS :
Share Capital 25.2717.1717.3917.5417.5417.6917.6917.6917.6817.67
Reserves Total 3,362.723,247.172,978.242,581.332,227.672,023.681,5501,173.17823.41575.64
Total Shareholders Funds3,387.993,264.342,995.632,598.872,245.212,041.371,567.691,190.86841.09593.31
Secured Loans 1.431.911.6945.6835.961.81.2859.6361.61119.2
Unsecured Loans 34.223.1229.6729.2800021.7210.7711.29
Total Debt35.6325.0331.3674.9635.961.81.2881.3572.38130.49
Other Liabilities27.8323.4122.5219.7813.7713.164.973.057.265.33
Total Liabilities3,451.453,312.783,049.512,693.612,294.942,056.331,573.941,275.26920.73729.13
APPLICATION OF FUNDS :
Gross Block 2,282.822,217.792,140.781,976.151,593.351,417.23879.01715.73549.85490.29
Less: Accumulated Depreciation786.38705.8599.67504.01415.12364.57289.84264.99261.76210.9
Net Block1,496.441,511.991,541.111,472.141,178.231,052.66589.17450.74288.09279.39
Capital Work in Progress209.47152.86108.19131.86261.6161.33339.26239.8170.293.55
Investments 535.37146.96175.6779.4277.73189.96181.5686.0459.563.46
Inventories 815.63791.07766.47495.68435.71350.63211.02204.58159.03155.4
Sundry Debtors 1,056.91,019.81738.43775.3459.48459.79323.15372.35258.76202.22
Cash and Bank Balance330.9211.79209.61205.25100.5193.0969.9543.37136.7660.39
Loans and Advances 111.48119.93137.4198.34119.37137.7364.9266.1959.447.04
Total Current Assets2,314.912,142.61,851.921,574.571,115.071,041.24669.04686.49613.95465.05
Current Liabilities 1,082.76622.18576.41523.06334.67312.79224.27182.06146.16154.53
Provisions 47.0918.7560.6320.867.6732.4722.1511.3564.342.7
Total Current Liabilities & Provisions1,129.85640.93637.04543.92342.34345.26246.42193.41210.46197.23
Net Current Assets1,185.061,501.671,214.881,030.65772.73695.98422.62493.08403.49267.82
Deferred Tax Assets131.0780.5760.2635.5662.8843.6136.4718.811.680.12
Deferred Tax Liability132.02126.89102.3391.3289.976839.3629.5216.8423.11
Net Deferred Tax-0.95-46.32-42.07-55.76-27.09-24.39-2.89-10.71-15.16-22.99
Other Assets26.0645.6251.7335.331.7380.7944.2216.3114.6147.9
Total Assets3,451.453,312.783,049.512,693.612,294.942,056.331,573.941,275.26920.73729.13
Contingent Liabilities4.557.2882.950.1346.1211.6813.8320.266.243.17
Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
SOURCES OF FUNDS :
Share Capital 25.2717.1717.3917.5417.5417.6917.6917.6917.6817.67
Reserves Total 3,221.183,152.012,867.592,443.762,124.541,913.811,486.251,114.01768.65518.65
Total Shareholders Funds3,246.453,169.182,884.982,461.32,142.081,931.51,503.941,131.7786.33536.32
Secured Loans 000000058.1360.08118.17
Unsecured Loans 32.920.4925.9123.490009.9510.7810.77
Total Debt32.920.4925.9123.4900068.0870.86128.94
Other Liabilities27.8323.4122.5219.7813.7713.164.983.047.265.33
Total Liabilities3,307.183,213.082,933.412,504.572,155.851,944.661,508.921,202.82864.45670.59
APPLICATION OF FUNDS :
Gross Block 2,246.282,163.182,086.541,926.651,555.611,379.38843.35679.21510.92449.57
Less : Accumulated Depreciation 762.27670.86567.75477.33393.59342.69270.42246.38239.6188.17
Net Block 1,484.011,492.321,518.791,449.321,162.021,036.69572.93432.83271.32261.4
Capital Work in Progress209.47152.86108.19131.06261.2961.33339.26239.8170.293.55
Investments 553.26164.85156.8885.7783200.64198.8294.0376.6278.84
Inventories 683.77635.11634.22436.19414.26317.37179.28189.78153.05148.77
Sundry Debtors 977.631,043.62782.3734.24423.38432.19336350.48240.85177.09
Cash and Bank Balance269.92145.25151.9887.8535.8738.6722.8421.44105.6929.08
Loans and Advances 101.68111.17128.7289.66110.21124.455.3959.9453.9843.71
Total Current Assets2,0331,935.151,697.221,347.94983.72912.63593.51621.64553.57398.65
Current Liabilities 874.39446.8459.91444.53299.09279.48191.4175.93141.94143.59
Provisions 25.518.7446.5718.897.6720.7120.8411.3664.342.71
Total Current Liabilities & Provisions899.89465.54506.48463.42306.76300.19212.24187.29206.24186.3
Net Current Assets1,133.111,469.611,190.74884.52676.96612.44381.27434.35347.33212.35
Deferred Tax Assets34.328.150002111.985.821.680.13
Deferred Tax Liability132.02130.0292.1781.1658.96839.3629.416.8423.11
Net Deferred Tax-97.72-101.87-92.17-81.16-58.9-47-27.38-23.58-15.16-22.98
Other Assets25.0535.3150.9835.0631.4880.5644.0225.3914.1447.43
Total Assets3,307.183,213.082,933.412,504.572,155.851,944.661,508.921,202.82864.45670.59
Contingent Liabilities4.557.2882.950.1346.1211.7713.9120.356.463.27

Cash Flow (Figures in Rs. Crores)

Net Profit before Tax and Extr...745.25
Depreciation130.8
Interest (Net)5.84
P/L on Sales of Assets6.19
Prov. and W/O (Net)-0.82
P/L in Forex-14.08
Others-1.11
Total Adjustments (PBT and Ext...131.3
Operating Profit before Workin...876.55
Trade and 0ther Receivables-10.55
Inventories-22.37
Trade Payables96.91
Loans and Advances-11.02
Total Adjustments (OP before W...66.52
Cash Generated from/(used in) ...943.07
Direct Taxes Paid-151.29
Total Adjustments(Cash Generat...-151.29
Cash Flow before Extraordinary...791.78
Net Cash from Operating Activi...791.78
Sale of Fixed Assets9.55
Purchase of Investments-1,666.86
Sale of Investments1,276.15
Net Cash used in Investing Act...-559.6
Of the Long Tem Borrowings-0.49
Of Financial Liabilities-14.25
Dividend Paid-89.69
Interest Paid-2.33
Net Cash used in Financing Act...-107.87
Net Profit before Tax and Extr...699.85
Depreciation126.95
Interest (Net)5.23
Dividend Received35.14
P/L on Sales of Assets1.52
Prov. and W/O (Net)-0.84
P/L in Forex-14.08
Others-1.44
Total Adjustments (PBT and Ext...79.34
Operating Profit before Workin...779.19
Trade and 0ther Receivables81.94
Inventories-48.67
Trade Payables78.46
Loans and Advances-10.88
Total Adjustments (OP before W...82.66
Cash Generated from/(used in) ...861.85
Direct Taxes Paid-125.56
Total Adjustments(Cash Generat...-125.56
Cash Flow before Extraordinary...736.29
Net Cash from Operating Activi...736.29
Sale of Fixed Assets0.57
Purchase of Investments-1,666.86
Sale of Investments1,276.15
Net Cash used in Investing Act...-501.31
Of Financial Liabilities-12.23
Dividend Paid-89.69
Interest Paid-1.76
Net Cash used in Financing Act...-105.12

Company Details

Registered Office
AddressAjanta House,
Charkop Kandivli (W)
CityMumbai
StateMaharashtra
Pin Code400067
Tel. No.91-22-66061000/1204/1203
Fax. No.91-22-66061200/1300
Emailinfo@ajantapharma.com; investorgrievance@ajantapha
Internethttp://www.ajantapharma.com
Registrars
AddressAjanta House
CityMumbai
StateMaharashtra
Pin Code400067
Tel. No.91-22-66061000/1204/1203
Fax. No.91-22-66061200/1300
Emailinfo@ajantapharma.com; investorgrievance@ajantapha
Internethttp://www.ajantapharma.com
Management
Name Designation
Mannalal B AgrawalChairman (Non-Executive)
Madhusudan B AgrawalVice Chairman
Yogesh AgrawalManaging Director
Chandrakanth M KhetanIndependent Director
Gaurang ShahVice President & CS
Rajesh M AgrawalJoint Managing Director
K H ViswanathanIndependent Director
Prabhakar DalalIndependent Director
Anjana GrewalIndependent Director